David A. Siegel Inotiv, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q4 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Inotiv, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 22,500 shares of NOTV stock, worth $58,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,500

Previous 17,100 31.58%

Holding current value

$58,950

Previous $29,000 220.69%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.68 - $5.95 $9,072 - $32,130	5,400 Added 31.58%	22,500 $93,000
Q3 2024 Nov 14, 2024	SELL	$1.28 - $2.26 $82,688 - $145,996	-64,600 Reduced 79.07%	17,100 $29,000
Q2 2024 Aug 14, 2024	SELL	$1.66 - $9.87 $8,466 - $50,336	-5,100 Reduced 5.88%	81,700 $135,000
Q1 2024 May 15, 2024	BUY	$3.27 - $11.04 $206,010 - $695,520	63,000 Added 264.71%	86,800 $949,000
Q4 2023 Feb 14, 2024	BUY	$1.69 - $3.86 $12,506 - $28,564	7,400 Added 45.12%	23,800 $87,000
Q3 2023 Nov 14, 2023	BUY	$3.01 - $7.32 $9,933 - $24,156	3,300 Added 25.19%	16,400 $50,000
Q2 2023 Aug 14, 2023	BUY	$4.08 - $7.22 $53,448 - $94,582	13,100 New	13,100 $62,000
Q2 2022 Aug 15, 2022	SELL	$9.56 - $25.91 $112,808 - $305,738	-11,800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$18.52 - $40.41 $1,852 - $4,040	100 Added 0.85%	11,800 $309,000
Q4 2021 Feb 14, 2022	SELL	$30.55 - $57.88 $1.58 Million - $3 Million	-51,800 Reduced 81.57%	11,700 $492,000
Q3 2021 Nov 15, 2021	BUY	$23.69 - $49.93 $28,428 - $59,916	1,200 Added 1.93%	63,500 $1.86 Million
Q2 2021 Aug 16, 2021	BUY	$18.9 - $31.42 $1.18 Million - $1.96 Million	62,300 New	62,300 $1.66 Million

Others Institutions Holding NOTV

# of Institutions

Shares Held

8.97M

Call Options Held

388K

Put Options Held

145K

View Full List

About Inotiv, Inc.

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $67.1M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

More about NOTV

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account